State Street’s Exagen XGN Stock Holding History
Bought
Maintained
Sold
Other funds holding XGN
WC
VCM
NCNMGF
SAM
KCM
FCM
RI
MBAM
State Street's XGN Position: Q1 2026 in Review
State Street held its Exagen (XGN) position steady in Q1 2026 at 71,256 shares worth $214K. The position accounts for ﹤0.01% of the portfolio, ranked #3866.
State Street first reported a position in XGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $1.73M in Q3 2021. 61 funds tracked by Wall St. Rank hold XGN as of Q1 2026.
- State Street held 71,256 shares of Exagen worth $214K as of Q1 2026.
- State Street left its Exagen share count unchanged in Q1 2026.
- Exagen made up ﹤0.01% of State Street's portfolio in Q1 2026, its #3866 holding.
- State Street first reported a position in Exagen in Q4 2019 and has held it in 26 quarters since.
- State Street's Exagen position peaked at $1.73M in Q3 2021.
- 61 funds tracked by Wall St. Rank held Exagen as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.